Nykode Therapeutics Selects BioConnection To Manufacture Direct Vax Applicant

BioConnection, an unbiased CDMO based mostly in The Netherlands, specialised in GMP -accredited producing of sterile drug merchandise in vials and syringes, has introduced that Nykode Therapeutics AS, (formerly Vaccibody), picked BioConnection for the aseptic Drug Product manufacturing of its Lead Vaccine prospect.
Nykode Therapeutics is a clinical phase Biotechnology enterprise, acquiring vaccines and novel immunotherapies for the therapy of cancer and Infectious Conditions with a superior unmet clinical want.
Mette Husbyn, CTO of Nykode, said, “We chose to companion with BioConnection for the production of Nykode’s precious clinical demo materials since of their tailored solutions for creation, matching the needs for tiny scale batches. Additionally, BioConnection has an exceptional broad producing and regulatory track record, including EMA and Fda certification.”
BioConnection’s CEO Alexander Willemse extra, “ Stage I trials typically have to have modest batches of drug merchandise that have to be delivered in a specific manner. Capitalizing on our a long time of experience, we offer you automated filling in substantial volumes up to 40 million vials for every calendar year, and importantly also handbook Fill and Finish . I’m very happy that our manufacturing capabilities, properly match Nykode’s exact early phase medical trial needs.”